Variability in Microbial Response to Dietary Fiber
NCT06023940 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2024-07-24
Summary
The goal of this clinical trial is to understand varying in responses to different dietary patterns in healthy people who are getting a health screening colonoscopy.
The main questions it aims to answer are:
* What is the variability in the change of the microbes in the gut of (1) a provided diet that is high in fiber vs (2) a diet of the participant's choice.
* What is the magnitude of fasting changes in glucose and lipids following the short-term, high-fiber feeding period and identify candidate predictive factors (short-chain fatty acids, BMI, sex, starting glucose level) for these changes
Participants will be in one of two groups:
1. High-fiber diet group: These participants will have a series of measurements that include: blood biochemistries, body composition measured via DEXA, anthropometrics, surveys and questionnaires, and collection of fecal samples.
2. Normal diet group: These participants will eat a diet that is of their choosing (ad libitum) and will have a series of measurements that include: fecal samples, and questionnaires/surveys including food records.
Conditions
- Microbial Colonization
Interventions
- DIETARY_SUPPLEMENT
-
High fiber
A pea fiber supplement is added to a diet of regular foods. Participants receive 25g fiber daily.
Sponsors & Collaborators
-
University of Missouri-Columbia
lead OTHER
Principal Investigators
-
Elizabeth Parks · University of Missouri-Columbia
-
Yezaz Ghouri, MD · University of Missouri-Columbia
-
Katherene Anguah, PhD · University of Missouri-Columbia
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 45 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-05-12
- Primary Completion
- 2023-10-31
- Completion
- 2023-10-31
Countries
- United States
Study Locations
More Related Trials
-
Microbiota or Placebo After Antimicrobial Therapy for Recurrent C. Difficile at Home (MATCH)
NCT03005379 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Multicentre Blinded Comparison of Lyophilized Sterile Fecal Filtrate to Lyophilized Fecal Microbiota Transplant in Recurrent Clostridioides Difficile Infection
NCT03806803 ·Status: COMPLETED ·Phase: PHASE2
-
Dietary Optimization of Microbiome Recovery Following Fecal Microbiota Transplantation
NCT05826418 ·Status: COMPLETED ·Phase: NA
-
Gut Microbiota Changes After Fecal Microbiota Transplantation
NCT02557685 ·Status: UNKNOWN ·Phase: PHASE2
-
Vancomycin Prophylaxis in Recurrent Clostridium Difficile Infection
NCT02237859 ·Status: UNKNOWN ·Phase: PHASE4
-
The Role of Mucosal Microbiome in Recurrence of Clostridioides Difficile Infection
NCT04675723 ·Status: COMPLETED
-
Intestinal Microbiota Transplantation in Patients Undergoing Colon Resection
NCT06370884 ·Status: RECRUITING ·Phase: PHASE1
-
Plant Based Diet, Ethnicity, and the Gut Microbiome
NCT03314194 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Skin, Colonic, and Oral Microbiome and Effect of Time and Antibiotic Treatment on Organism Diversity at Each Site
NCT01143571 ·Status: COMPLETED
-
Stool Transplant to Control Treatment-related Diarrhea
NCT04883762 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Longitudinal Study of the Human Intestinal Microbiome
NCT00832286 ·Status: COMPLETED ·Phase: PHASE1
-
High- Fiber/ Low-fat Diet for Prevention of Recurrent Clostridioides Difficile Infection in Oncology
NCT04940468 ·Status: COMPLETED ·Phase: NA
-
Fecal Microbiota Therapy for Recurrent Clostridium Difficile Infection
NCT02686645 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Evaluation of the Variation of the Intestinal Microbiota and the Integrity of the Intestinal Barrier in Patients With M.D.R. Germ-induced Pneumonia Undergoing Enteral Nutrition
NCT06485791 ·Status: NOT_YET_RECRUITING
-
Fecal Microbiota Transplant
NCT04090346 ·Status: COMPLETED ·Phase: PHASE4
-
Metabolome and Microbiomic in Fecal Samples
NCT00938028 ·Status: COMPLETED
-
FMT Versus Antimicrobials for Initial Treatment of Recurrent CDI
NCT02255305 ·Status: TERMINATED ·Phase: PHASE2
-
Intestinal Microbiota of Patients Hospitalized With Sars-CoV-2
NCT05178238 ·Status: ACTIVE_NOT_RECRUITING
-
A Novel Fecal Sample Collection Method for Metagenomic Analyses
NCT05172414 ·Status: COMPLETED
-
Studies of the Human Microbiome in Clinical Center Patients
NCT01933620 ·Status: ENROLLING_BY_INVITATION
-
A Flexible Clinical Trial to Test if Freeze-dried Fecal Microbiota Therapy Helps Treat Diarrhea-predominant Irritable Bowel Syndrome or Prevent Recurring C. Difficile Infections.
NCT06948461 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Fecal Transplant +/- Gut Decontamination in Preventing Acute Graft Versus Host Disease in Patients Given Broad-Spectrum Antibiotics
NCT03862079 ·Status: WITHDRAWN ·Phase: PHASE2
-
Mucosal Versus Fecal Microbiota in FMT
NCT02133651 ·Status: COMPLETED
-
Advanced Metagenomic Analysis of Human Colonic Microbiota in Patients With Chronic GI Disorders
NCT01099111 ·Status: COMPLETED
-
Fecal Microbiota Transplantation by Colonoscopy for Recurrent C. Difficile Infection
NCT02148601 ·Status: COMPLETED ·Phase: PHASE2